相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The CYP2D6 gene determines oxycodone's phenotype-specific addictive potential: Implications for addiction prevention and treatment
Oscar A. Linares et al.
MEDICAL HYPOTHESES (2014)
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
N. Marsousi et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Opioid-induced respiratory depression in paediatrics: a review of case reports
M. Niesters et al.
BRITISH JOURNAL OF ANAESTHESIA (2013)
Opioid genetics: the key to personalized pain control?
R. Branford et al.
CLINICAL GENETICS (2012)
Pharmacogenetics in perioperative medicine
Mindy Cohen et al.
CURRENT OPINION IN ANESTHESIOLOGY (2012)
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
Trine Naalsund Andreassen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy
Merja Kokki et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Central Nervous System Depression of Neonates Breastfed by Mothers Receiving Oxycodone for Postpartum Analgesia
Jessica Lam et al.
JOURNAL OF PEDIATRICS (2012)
Pharmacogenomics of Codeine, Morphine, and Morphine-6-Glucuronide Model-Based Analysis of the Influence of CYP2D6 Activity, UGT2B7 Activity, Renal Impairment, and CYP3A4 Inhibition
Thomas Eissing et al.
MOLECULAR DIAGNOSIS & THERAPY (2012)
Preventing Opioid-Related Deaths in Children Undergoing Surgery
Senthilkumar Sadhasivam et al.
PAIN MEDICINE (2012)
The severity and duration of postoperative pain and analgesia requirements in children after tonsillectomy, orchidopexy, or inguinal hernia repair
David W. Stewart et al.
PEDIATRIC ANESTHESIA (2012)
An audit of pain management following pediatric day surgery at British Columbia Children's Hospital
Serena Shum et al.
PAIN RESEARCH & MANAGEMENT (2012)
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
C. F. Samer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The Hypoalgesic Effect of Oxycodone in Human Experimental Pain Models in Relation to the CYP2D6 Oxidation Polymorphism
Stine T. Zwisler et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)
Kanako Sakuyama et al.
DRUG METABOLISM AND DISPOSITION (2008)
Pharmacogenetic insights analgesia: implications to into codeine pediatric codeine use
Parvaz Madadi et al.
PHARMACOGENOMICS (2008)
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
D. Campa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer
Margaret T. Susce et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites
Bojan Lalovic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Postoperative pain, nausea and vomiting following paediatric day-case tonsillectomy
BN Ewah et al.
ANAESTHESIA (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Genetic polymorphism and drug interactions: their importance in the treatment of pain
CF Samer et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2005)
Codeine intoxication associated with ultrarapid CYP2D6 metabolism
Y Gasche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers
J de Leon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6
T Fukuda et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
分享论文
